- Home
- ALCE vs PULM Comparison
ALCE vs PULM Comparison
Compare ALCE & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCE
- PULM
- Stock Information
- Founded
- ALCE 2019
- PULM 2003
- Country
- ALCE United States
- PULM United States
- Employees
- ALCE N/A
- PULM N/A
- Industry
- ALCE Power Generation
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- ALCE Utilities
- PULM Health Care
- Exchange
- ALCE Nasdaq
- PULM Nasdaq
- Market Cap
- ALCE 8.6M
- PULM 7.4M
- IPO Year
- ALCE N/A
- PULM N/A
- Fundamental
- Price
- ALCE $1.75
- PULM $6.56
- Analyst Decision
- ALCE
- PULM
- Analyst Count
- ALCE 0
- PULM 0
- Target Price
- ALCE N/A
- PULM N/A
- AVG Volume (30 Days)
- ALCE 208.7K
- PULM 1.2M
- Earning Date
- ALCE 11-26-2024
- PULM 11-08-2024
- Dividend Yield
- ALCE N/A
- PULM N/A
- EPS Growth
- ALCE N/A
- PULM N/A
- EPS
- ALCE N/A
- PULM N/A
- Revenue
- ALCE N/A
- PULM $10,005,000.00
- Revenue This Year
- ALCE N/A
- PULM N/A
- Revenue Next Year
- ALCE N/A
- PULM $1.00
- P/E Ratio
- ALCE N/A
- PULM N/A
- Revenue Growth
- ALCE N/A
- PULM 47.05
- 52 Week Low
- ALCE $1.64
- PULM $1.55
- 52 Week High
- ALCE $272.25
- PULM $7.87
- Technical
- Relative Strength Index (RSI)
- ALCE 25.53
- PULM 94.68
- Support Level
- ALCE $1.71
- PULM $2.00
- Resistance Level
- ALCE $2.20
- PULM $7.87
- Average True Range (ATR)
- ALCE 0.28
- PULM 0.65
- MACD
- ALCE 0.00
- PULM 0.40
- Stochastic Oscillator
- ALCE 9.43
- PULM 77.68
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.